Other
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10
CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 increased by 18.9% to $5.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.6%, from $4.39B to $5.69B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ2 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_securities_debt_maturities_afte_2a379cHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.68B | $4.72B | $4.97B | $4.56B | $4.35B | $4.3B | $4.08B | $3.89B | $4.46B | $4.29B | $4.89B | $4.39B | $4.56B | $4.78B | $5.69B |
| QoQ Change | — | +0.8% | +5.2% | -8.2% | -4.7% | -1.1% | -5.1% | -4.6% | +14.7% | -3.9% | +14.0% | -10.3% | +4.1% | +4.8% | +18.9% |
| YoY Change | — | — | — | -2.6% | -7.9% | -13.4% | -10.6% | -10.5% | +3.8% | +5.1% | +25.7% | -1.7% | +6.4% | -2.2% | +29.6% |
Range$3.89B – $5.69B
CAGR+5.7%
Avg YoY Growth+1.8%
Median YoY Growth-2.0%
Current Streak3 quarters growth
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 5 through 10?
- CVS Health (CVS) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 5 through 10 of $5.69B in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 5 through 10 changed year-over-year?
- CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year 5 through 10 increased by 29.6% year-over-year, from $4.39B to $5.69B.